Secure shopping
Healthcare and pharma
The Pharma & Healthcare industry is of vital importance for human and economic development, providing a wide range of goods and services relevant to the promotion of health at all stages in the healthcare process – from prevention and treatment to rehabilitation and palliative care. It is one of the fastest-growing industries, supported by profound demographic changes, the rising incidence of non-communicable diseases, and surging per capita health spending in both developed and emerging markets. The industry is also one of the major innovators, with increasing expenditures on development of new molecules, biotechnology and adoption of new technologies that provide advanced healthcare and ensure the longevity of the population.
The Pharma & Healthcare industry comprises the manufacture of pharmaceuticals for human and veterinary use, medical equipment and related supplies. It also includes providers of ambulatory health services, medical and diagnostic laboratories, hospitals, and nursing and residential care facilities.
Expenditure on healthcare in Romania reached RON 35.2bn in 2015, according to data provided by Eurostat. Total expenditure on healthcare was equal to 4.94% of GDP in that year. The Romanian healthcare sector was characterised by the lowest per capita ...
View more details
Total expenditure on healthcare in Hungary in 2015 reached HUF 2,460bn, up by 6.3% y/y. Government and compulsory health care financing schemes made up 67% of the expenditure, followed by private out-of-pocket spending (29%). Voluntary healthcare ...
View more details
In 2016 Poland’s healthcare expenditure grew by 4.5% y/y to PLN 119.27bn, representing 6.4% of the GDP. Public healthcare spending in Poland is one of the lowest compared to the EU average, which hovers around 6.5 % of GDP. The bulk of the ...
View more details
Russia’s healthcare and pharmaceutical sector was badly affected by the 2015-2016 recession, which resulted in a sharp drop in government spending, while the weak rouble and high inflation cut into households’ disposable incomes. Though ...
View more details
The pharmaceutical sector in the Czech Republic generated a gross value added (GVA) of CZK 18.9bn in 2016, up by 8.2% y/y in real terms. It accounted for 0.44% of the total GVA in the economy in 2016. The sector employed 9,438 workers. Total ...
View more details
In 2015, the total Hungarian healthcare expenditure amounted to HUF 2,373.4bn, or 7.04% of GDP. Public financing schemes made up 67.1% of the healthcare spending. By regional standards, the Hungarian health spending as a percentage of GDP is high, ...
View more details
The Russian healthcare and pharmaceutical sector is suffering under the impact of ongoing recession in the Russian economy and depressed domestic demand. The healthcare system is in dire need of financing as lower oil prices and a sharply devalued ...
View more details
The Czech pharmaceutical sector is very attractive for international pharmaceutical manufacturers due to the favourable cost-efficiency ratio. The pharmaceutical sector generated a GVA of CZK 17.9bn in 2015, accounting for 0.4% of the total GVA. ...
View more details